Tags Reports - Allied Market Research

sale

Oncolytic Virus Immunotherapy Market

U

2026

Oncolytic Virus Immunotherapy Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

The oncolytic virus immunotherapy involves the use of viruses to infect and subsequently eliminate cancerous cells. Cancer cells are known to exhibit impaired antiviral defenses, which make them ...

Report Code : A11451 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Virus Testing Kit Market

U

2026

Virus Testing Kit Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Virus testing diagnostic kit is used for the detection and diagnosis of various types of viral infections. It is necessary as it provides effective and timely detection of ...

Report Code : A12486 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Rabies Vaccine Market

P

2025

Rabies Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2025-2034

The global rabies vaccine market was valued at $1.3 billion in 2024, and is projected to reach $2 billion by 2034, growing at a CAGR of 4.5% from 2025 to 2034.

Report Code : A02924 | Pages : 319 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Australia Vaccines Market

P

2024

Australia Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The Australia vaccines market was valued at $0.6 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

Report Code : A325353 | Pages : 90 | Category : Life Sciences

Price:

~~$1,859~~ $1,301 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

UK Vaccines Market

P

2024

UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The UK vaccines market was valued at $1.4 billion in 2023, and is projected to reach $3.0 billion by 2033, growing at a CAGR of 7.7% from 2024 to 2033.

Report Code : A325352 | Pages : 150 | Category : Life Sciences

Price:

~~$1,991~~ $1,394 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Newcastle Disease Vaccine Market by Vaccine Type

P

2024

Newcastle Disease Vaccine Market by Vaccine Type : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global newcastle disease vaccine market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.

Report Code : A324484 | Pages : 216 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Vaccines Market

P

2024

U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The U.S. vaccines market was valued at $16.4 billion in 2023, and is projected to reach $29.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Report Code : A325351 | Pages : 90 | Category : Life Sciences

Price:

~~$2,177~~ $1,524 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Asia-Pacific Vaccines Market

P

2024

Asia-Pacific Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The Asia-Pacific vaccines market was valued at $9.8 billion in 2023, and is projected to reach $19.9 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.

Report Code : A325350 | Pages : 130 | Category : Life Sciences

Price:

~~$1,859~~ $1,301 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Europe Vaccines Market

P

2024

Europe Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The Europe vaccines market was valued at $12.1 billion in 2023, and is projected to reach $22.3 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.

Report Code : A325349 | Pages : 150 | Category : Life Sciences

Price:

~~$2,257~~ $1,580 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

North America Vaccines Market

P

2024

North America Vaccines Market: Opportunity Analysis and Industry Forecast, 2024 - 2033

The North America vaccines market was valued at $18.0 billion in 2023, and is projected to reach $32.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Report Code : A325348 | Pages : 110 | Category : Life Sciences

Price:

~~$2,443~~ $1,710 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Asia-Pacific Dengue Virus Diagnostic Test Market

P

2024

Asia-Pacific Dengue Virus Diagnostic Test Market: Global Opportunity Analysis and Industry Forecast, 2024-2035

The Asia-Pacific dengue virus diagnostic test market size was valued at $ 53.25 million in 2023 and is projected to reach $ 99.45 million by 2035, registering a CAGR of 5.3% from 2024 to 2035.According to the report published by the Allied Market Research, the

Report Code : A325386 | Pages : 300 | Category : Life Sciences

Price:

~~$2,169~~ $1,518 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Results for Tags: virus

Filter by Region

Filter by Discounts

Filter by Category

The oncolytic virus immunotherapy involves the use of viruses to infect and subsequently eliminate cancerous cells. Cancer cells are known to exhibit impaired antiviral defenses, which make them ...

Virus testing diagnostic kit is used for the detection and diagnosis of various types of viral infections. It is necessary as it provides effective and timely detection of ...

The global rabies vaccine market was valued at $1.3 billion in 2024, and is projected to reach $2 billion by 2034, growing at a CAGR of 4.5% from 2025 to 2034.

The Australia vaccines market was valued at $0.6 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

The UK vaccines market was valued at $1.4 billion in 2023, and is projected to reach $3.0 billion by 2033, growing at a CAGR of 7.7% from 2024 to 2033.

The global newcastle disease vaccine market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.

The U.S. vaccines market was valued at $16.4 billion in 2023, and is projected to reach $29.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

The Asia-Pacific vaccines market was valued at $9.8 billion in 2023, and is projected to reach $19.9 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.

The Europe vaccines market was valued at $12.1 billion in 2023, and is projected to reach $22.3 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.

The North America vaccines market was valued at $18.0 billion in 2023, and is projected to reach $32.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

The Asia-Pacific dengue virus diagnostic test market size was valued at $ 53.25 million in 2023 and is projected to reach $ 99.45 million by 2035, registering a CAGR of 5.3% from 2024 to 2035.According to the report published by the Allied Market Research, the